FDA approves the first postpartum depression pill

The FDA approved the first pill for postpartum depression on Friday. The drug is called zuranolone, and unlike other antidepressants, it's specifically designated for postpartum depression, a condition that affects around 1 in 7 new mothers.

The big picture: Zuranolone is taken daily for two weeks. Clinical trials showed that the drug could ease depression in as little as three days.

• Plus, young workers are redefining the American dream.
• And, Spanglish is making a comeback.

Guests: Axios' Felix Salmon, Arielle Dreher and Marina Franco.

Credits: Axios Today is produced by Erica Pandey, Alexandra Botti, Fonda Mwangi, Robin Linn and Alex Sugiura. Music is composed by Evan Viola. You can reach us at podcasts@axios.com. You can text questions, comments and story ideas to Niala as a text or voice memo to 202-918-4893.